Dashboard
Manage Tickers

ORTXOrchard Therapeutics plc

Nasdaq orchard-tx.com


$ 16.71 $ 0.05 (0.3 %)    

Tuesday, 23-Jan-2024 15:59:27 EST
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 431.01 $ 6.55 (1.54 %)
DIA $ 382.27 $ 1.39 (0.36 %)
SPY $ 508.26 $ 4.77 (0.95 %)
TLT $ 88.26 $ 0.46 (0.52 %)
GLD $ 216.60 $ 0.70 (0.32 %)
$ 16.7
$ 16.63
$ 0.00 x 0
$ 0.00 x 0
$ 16.63 - $ 16.72
$ 4.24 - $ 16.72
372,349
na
3.8B
$ 1.13
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 11-13-2023 09-30-2023 10-Q
2 08-10-2023 06-30-2023 10-Q
3 05-15-2023 03-31-2023 10-Q
4 03-14-2023 12-31-2022 10-K
5 11-14-2022 09-30-2022 10-Q
6 08-04-2022 06-30-2022 10-Q
7 05-12-2022 03-31-2022 10-Q
8 03-30-2022 12-31-2021 10-K
9 11-04-2021 09-30-2021 10-Q
10 08-04-2021 06-30-2021 10-Q
11 05-13-2021 03-31-2021 10-Q
12 03-02-2021 12-31-2020 10-K
13 11-03-2020 09-30-2020 10-Q
14 08-06-2020 06-30-2020 10-Q
15 05-07-2020 03-31-2020 10-Q
16 02-27-2020 12-31-2019 10-K
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

orchard-therapeutics-reached-an-agreement-with-the-beneluxa-initiative-on-pharmaceutical-policy-beneluxa-enabling-reimbursed-access-to-libmeldy-atidarsagene-autotemcel-approved-for-the-treatment-of-early-onset-metachromatic-leukodystrophy-mld
Orchard Therapeutics Reached An Agreement ...
01/25/2024 12:16:06

kyowa-kirin-completes-acquisition-of-orchard-therapeutics
Kyowa Kirin Completes Acquisition Of Orcha...
01/24/2024 10:34:22

The acquisition of all outstanding shares of Orchard Therapeutics by way of a Scheme of Arrangement procedure under the UK Comp...

orchard-therapeutics-wins-swissmedic-approval-for-libmeldy-in-early-onset-metachromatic-leukodystrophy-mld
Orchard Therapeutics Wins Swissmedic Appro...
12/11/2023 12:02:14

Orchard Therapeutics (NASDAQ:ORTX), a global gene therapy leader, today announced the Swiss Agency for Therapeutic Products (Sw...

orchard-therapeutics-received-fda-fast-track-designation-for-otl-203-an-investigational-hematopoietic-stem-cell-gene-therapy-being-developed-for-the-potential-treatment-of-the-hurler-subtype-of-mucopolysaccharidosis-type-i
Orchard Therapeutics Received FDA Fast Tra...
11/30/2023 12:04:05

on-november-15-2023-the-us-fda-informed-orchard-therapeutics-it-will-not-schedule-an-advisory-committee-meeting-for-the-review-of-the-cos-biologics-license-application-for-the-commercialization-of-otl-200-in-the-us-to-treat-metachromatic-leukodystrophy
On November 15, 2023, The US FDA Informed ...
11/21/2023 13:13:50

- SEC Filing

orchard-therapeutics-q3-earnings-insights
Orchard Therapeutics: Q3 Earnings Insights
11/13/2023 12:15:05

crude-oil-down-2-conagra-brands-earnings-top-views
Crude Oil Down 2%; ConAgra Brands Earnings...
10/05/2023 18:31:00

U.S. stocks traded slightly lower toward the end of trading, with the Dow Jones index falling around 40 points on Thursday. Th...

12-health-care-stocks-moving-in-thursdays-intraday-session
12 Health Care Stocks Moving In Thursday's...
10/05/2023 17:31:18

why-accolade-shares-are-trading-lower-by-around-10-here-are-other-stocks-moving-in-thursdays-mid-day-session
Why Accolade Shares Are Trading Lower By A...
10/05/2023 17:22:58

Gainers Orchard Therapeutics plc (NASDAQ: ORTX) shares climbed 97.7% to $15.98 after the company agreed to be acquired by J...

dow-tumbles-over-100-points-constellation-brands-raises-profit-forecast
Dow Tumbles Over 100 Points; Constellation...
10/05/2023 16:10:53

U.S. stocks traded lower midway through trading, with the Dow Jones index falling more than 100 points on Thursday. The Dow tr...

benzingas-top-ratings-upgrades-downgrades-for-october-5-2023
Benzinga's Top Ratings Upgrades, Downgrade...
10/05/2023 15:00:45

stifel-downgrades-orchard-therapeutics-to-hold-announces-16-price-target
Stifel Downgrades Orchard Therapeutics to ...
10/05/2023 14:36:26

Stifel analyst Dae Gon Ha downgrades Orchard Therapeutics (NASDAQ:ORTX) from Buy to Hold and announces $16 price target.

lamb-weston-sp-plus-and-other-big-stocks-moving-higher-on-thursday
Lamb Weston, SP Plus And Other Big Stocks ...
10/05/2023 14:09:53

U.S. stocks traded lower, with the Nasdaq Composite falling around 100 points on Thursday. Here are some big stocks recording g...

dow-falls-50-points-weekly-jobless-claims-edge-higher
Dow Falls 50 Points; Weekly Jobless Claims...
10/05/2023 13:44:02

U.S. stocks traded lower this morning, following the release of economic reports. Following the market opening Thursday, the D...

why-orchard-therapeutics-shares-are-trading-higher-by-around-95-here-are-20-stocks-moving-premarket
Why Orchard Therapeutics Shares Are Tradin...
10/05/2023 12:15:22

Gainers

why-gene-therapy-company-orchard-therapeutics-stock-is-skyrocketing-today
Why Gene Therapy Company Orchard Therapeut...
10/05/2023 10:25:56

Gene therapy company Orchard Therapeutics Plc (NASDAQ: ORTX) shares are trading higher after it agreed to be acquired by Kyowa ...

orchard-therapeutics-inked-a-deal-with-kyowa-kirin-to-be-acquired-for-1600ads-in-cash-plus-an-additional-contingent-value-right-of-100ads-representing-a-total-value-of-about-4776m
Orchard Therapeutics Inked A Deal With Kyo...
10/05/2023 07:46:30

Kyowa Kirin Co., Ltd. (Kyowa Kirin, TSE: 4151), a Japan-based global specialty pharmaceutical company (J-GSP) creating innovati...

orchard-therapeutics-announced-acceptance-of-biologics-license-application-for-otl-200-in-mld-and-receives-priority-review
Orchard Therapeutics Announced Acceptance ...
09/18/2023 11:37:47

Orchard Therapeutics (NASDAQ:ORTX), a global gene therapy leader, today announced the U.S. Food and Drug Administration (FDA) h...

orchard-therapeutics-reports-acceptance-of-biologics-license-application-for-otl-200-in-mld-and-receives-priority-review
Orchard Therapeutics Reports Acceptance Of...
09/18/2023 11:01:44

oppenheimer-reiterates-outperform-on-orchard-therapeutics-maintains-34-price-target
Oppenheimer Reiterates Outperform on Orcha...
08/09/2023 13:59:43

Oppenheimer analyst Kevin DeGeeter reiterates Orchard Therapeutics (NASDAQ:ORTX) with a Outperform and maintains $34 price t...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION